Suppr超能文献

马来西亚人对 COVID-19 疫苗的接受程度和关注情况调查。

A survey on COVID-19 vaccine acceptance and concern among Malaysians.

机构信息

Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak, 94300, Kota Samarahan, Sarawak, Malaysia.

出版信息

BMC Public Health. 2021 Jun 12;21(1):1129. doi: 10.1186/s12889-021-11071-6.

Abstract

BACKGROUND

Vaccination is an effective way to curtail the burden of COVID-19 in which success depends on a high acceptance of the vaccine. However, addressing concerns among vaccine-hesitant individuals is essential to avoid failure of the immunisation programme. This study sought to assess the concerns and acceptance rates regarding the COVID-19 vaccine among Malaysians.

METHODS

An online questionnaire was distributed to 1411 respondents via a snowball sampling method among Malaysians aged 18 years and above.

RESULTS

The majority of the respondents were young adults (40.7%), female (62.8%), Malay (63.8%), Muslim (72.3%), married (52.9%), with tertiary education (86.8%) and without medical illness (85%). Social media (97.4%) was the primary source of information regarding COVID-19. The overall acceptance rate was high (83.3%), with the lowest rates among the elderly aged 60 years and above (63.4%) and pensioners (64.6%). Hesitance was caused by concerns regarding side effects (95.8%), safety (84.7%), lack of information (80.9%), effectiveness (63.6%) and religious (20.8%) and cultural factors related to the COVID-19 vaccine (6.8%). Respondents with diabetes mellitus (24.7%) and hypercholesterolemia (23%) were more hesitant to accept the COVID-19 vaccine, at 16.1 and 15.8%, respectively. Predictors of COVID-19 vaccine hesitance were age, religion, and current residence.

CONCLUSIONS

The results indicate a high rate of acceptance of the COVID-19 vaccine among Malaysians. Thus, the Malaysian government and other related agencies should increase their campaign and prepare to implement the COVID-19 mass immunisation programme among Malaysians. However, despite the high acceptance rate, it remains important to address concerns among hesitant individuals by building trust in vaccine safety and effectiveness through adequate information regarding the vaccine.

摘要

背景

接种疫苗是减轻 COVID-19 负担的有效方法,成功与否取决于疫苗的高接受度。然而,解决疫苗犹豫者的担忧对于避免免疫计划的失败至关重要。本研究旨在评估马来西亚人对 COVID-19 疫苗的担忧和接受率。

方法

通过滚雪球抽样法向 1411 名年龄在 18 岁及以上的马来西亚人在线分发问卷。

结果

大多数受访者是年轻人(40.7%)、女性(62.8%)、马来人(63.8%)、穆斯林(72.3%)、已婚(52.9%)、具有高等教育学历(86.8%)和没有患病(85%)。社交媒体(97.4%)是有关 COVID-19 的主要信息来源。总体接受率很高(83.3%),其中 60 岁及以上的老年人(63.4%)和养老金领取者(64.6%)的接受率最低。犹豫不决的原因是担心副作用(95.8%)、安全性(84.7%)、缺乏信息(80.9%)、有效性(63.6%)以及与 COVID-19 疫苗相关的宗教(20.8%)和文化因素(6.8%)。患有糖尿病(24.7%)和高胆固醇血症(23%)的受访者更不愿意接受 COVID-19 疫苗,分别为 16.1%和 15.8%。COVID-19 疫苗犹豫的预测因素是年龄、宗教和当前居住地。

结论

结果表明马来西亚人对 COVID-19 疫苗的接受率很高。因此,马来西亚政府和其他相关机构应加大宣传力度,为马来西亚人准备实施 COVID-19 大规模免疫计划。然而,尽管接受率很高,但仍有必要通过提供有关疫苗的充分信息来建立对疫苗安全性和有效性的信任,解决犹豫不决者的担忧。

相似文献

1
A survey on COVID-19 vaccine acceptance and concern among Malaysians.
BMC Public Health. 2021 Jun 12;21(1):1129. doi: 10.1186/s12889-021-11071-6.
2
COVID-19 Vaccine Acceptance and Uptake in Bangkok, Thailand: Cross-sectional Online Survey.
JMIR Public Health Surveill. 2023 Apr 13;9:e40186. doi: 10.2196/40186.
3
Willingness to Be Vaccinated against COVID-19 in Spain before the Start of Vaccination: A Cross-Sectional Study.
Int J Environ Res Public Health. 2021 May 15;18(10):5272. doi: 10.3390/ijerph18105272.
4
SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.
Hum Vaccin Immunother. 2021 Nov 2;17(11):4048-4056. doi: 10.1080/21645515.2021.1958611. Epub 2021 Aug 6.
6
The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal.
BMC Public Health. 2022 Feb 14;22(1):296. doi: 10.1186/s12889-022-12632-z.
7
Acceptance of COVID-19 vaccination and vaccine confidence levels in Thailand: A cross-sectional study.
Vaccine. 2023 Oct 20;41(44):6589-6598. doi: 10.1016/j.vaccine.2023.09.018. Epub 2023 Sep 22.
8
Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population.
Hum Vaccin Immunother. 2021 Oct 3;17(10):3365-3370. doi: 10.1080/21645515.2021.1944743. Epub 2021 Jul 8.
9
Sociodemographic predictors of COVID-19 vaccine acceptance: a nationwide US-based survey study.
Public Health. 2021 Sep;198:252-259. doi: 10.1016/j.puhe.2021.07.028. Epub 2021 Jul 29.

引用本文的文献

1
A cross-sectional study of the predictors of COVID-19 vaccine hesitancy in Pakistan.
Hum Vaccin Immunother. 2025 Dec;21(1):2549164. doi: 10.1080/21645515.2025.2549164. Epub 2025 Aug 27.
4
Global COVID-19 vaccine hesitancy among elderly: A systematic review.
Vaccine X. 2024 Nov 15;21:100584. doi: 10.1016/j.jvacx.2024.100584. eCollection 2024 Dec.
5
Comparing role of religion in perception of the COVID-19 vaccines in Africa and Asia Pacific.
Commun Med (Lond). 2024 Oct 24;4(1):212. doi: 10.1038/s43856-024-00628-2.
7
Gendered (SDG5) and other perspectives on COVID-19 vaccination status: a focus on South Africa's Limpopo province.
Front Glob Womens Health. 2024 Jul 30;5:1420967. doi: 10.3389/fgwh.2024.1420967. eCollection 2024.
10
The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.
PLoS One. 2024 Apr 30;19(4):e0301383. doi: 10.1371/journal.pone.0301383. eCollection 2024.

本文引用的文献

2
Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study.
Brain Behav Immun. 2021 May;94:41-50. doi: 10.1016/j.bbi.2021.03.008. Epub 2021 Mar 11.
3
COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment.
J Community Health. 2021 Apr;46(2):270-277. doi: 10.1007/s10900-020-00958-x. Epub 2021 Jan 3.
4
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
5
The UK has approved a COVID vaccine - here's what scientists now want to know.
Nature. 2020 Dec;588(7837):205-206. doi: 10.1038/d41586-020-03441-8.
6
Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey.
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663. doi: 10.2147/JMDH.S276771. eCollection 2020.
7
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
Lancet. 2020 Nov 21;396(10263):1614-1616. doi: 10.1016/S0140-6736(20)32318-7. Epub 2020 Nov 4.
8
First vaccine may stymie hunt for better ones.
Science. 2020 Oct 23;370(6515):389-390. doi: 10.1126/science.370.6515.389.
9
A global survey of potential acceptance of a COVID-19 vaccine.
Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.
10
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
N Engl J Med. 2020 Nov 5;383(19):e107. doi: 10.1056/NEJMp2031373. Epub 2020 Oct 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验